Poster Session 2
P2.01: LUME-MeSO: Phase II/III Study of Nintedanib + Pemetrexed/Cisplatin in Patients With Malignant Pleural Mesothelioma: Track: SCLC, Mesothelioma, Thymoma

https://doi.org/10.1016/j.jtho.2016.08.075Get rights and content
Under an Elsevier user license
open archive

Cited by (0)